Javascript must be enabled to continue!
2394 Development of Hepatic Infarct After Successful Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement
View through CrossRef
INTRODUCTION:
Transjugular intrahepatic portosystemic shunt (TIPS) placement has now been well established as an effective and considered relatively safe treatment for the management of sequelae of portal hypertension. Hepatic infarction is an uncommon, potentially fatal complication after a TIPS procedure but rarely reported in cirrhosis patients with a low MELD (Model for End Stage Liver Disease). Here, we present a case of large hepatic infarct developing within a day of successful placement of TIPS in a patient with low MELD, which resolved with supportive treatment.
CASE DESCRIPTION/METHODS:
We present a 55 y/o Caucasian lady with Laennec cirrhosis with MELD 15 and normal bilirubin, who underwent elective TIPS placement for refractory ascites at our tertiary care center. Patient tolerated the procedure well with normal monitored vitals post procedure. However, she started complaining of right upper quadrant abdominal pain on next day with elevated transaminases and INR (40- fold and 2- fold increase from her baseline, respectively) with a stable bilirubin, CBC and creatinine. CT triple phase of the liver revealed a large hypodensity involving segments 6, 7 of the liver, suggestive of massive hepatic infarction and a patent TIPS. Patient not being a suitable candidate for liver transplant (with a history of recently diagnosed bladder carcinoma), was managed with supportive measures- Fluid, albumin, pain control and antibiotics. Liver enzymes continued to improve with return to baseline in 2 weeks. Subsequent clinic follow up showed complete control of ascites.
DISCUSSION:
Potential sequelae of TIPS are reported more frequently in cirrhotic with a MELD score greater than 18. Hepatic infarction is an uncommon development after a TIPS procedure. However, physicians must be aware of this virtually serious, post TIPS complication in cirrhotics even with a low MELD, which may progress to acute liver failure, with a need for liver transplant. Though our patient responded to supportive care, we think, an ideal patient planned for elective TIPS should be aware of this rare phenomenon. Prompt diagnosis is imperative to decrease the mortality from hepatic infarction.
Ovid Technologies (Wolters Kluwer Health)
Title: 2394 Development of Hepatic Infarct After Successful Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement
Description:
INTRODUCTION:
Transjugular intrahepatic portosystemic shunt (TIPS) placement has now been well established as an effective and considered relatively safe treatment for the management of sequelae of portal hypertension.
Hepatic infarction is an uncommon, potentially fatal complication after a TIPS procedure but rarely reported in cirrhosis patients with a low MELD (Model for End Stage Liver Disease).
Here, we present a case of large hepatic infarct developing within a day of successful placement of TIPS in a patient with low MELD, which resolved with supportive treatment.
CASE DESCRIPTION/METHODS:
We present a 55 y/o Caucasian lady with Laennec cirrhosis with MELD 15 and normal bilirubin, who underwent elective TIPS placement for refractory ascites at our tertiary care center.
Patient tolerated the procedure well with normal monitored vitals post procedure.
However, she started complaining of right upper quadrant abdominal pain on next day with elevated transaminases and INR (40- fold and 2- fold increase from her baseline, respectively) with a stable bilirubin, CBC and creatinine.
CT triple phase of the liver revealed a large hypodensity involving segments 6, 7 of the liver, suggestive of massive hepatic infarction and a patent TIPS.
Patient not being a suitable candidate for liver transplant (with a history of recently diagnosed bladder carcinoma), was managed with supportive measures- Fluid, albumin, pain control and antibiotics.
Liver enzymes continued to improve with return to baseline in 2 weeks.
Subsequent clinic follow up showed complete control of ascites.
DISCUSSION:
Potential sequelae of TIPS are reported more frequently in cirrhotic with a MELD score greater than 18.
Hepatic infarction is an uncommon development after a TIPS procedure.
However, physicians must be aware of this virtually serious, post TIPS complication in cirrhotics even with a low MELD, which may progress to acute liver failure, with a need for liver transplant.
Though our patient responded to supportive care, we think, an ideal patient planned for elective TIPS should be aware of this rare phenomenon.
Prompt diagnosis is imperative to decrease the mortality from hepatic infarction.
Related Results
Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients
Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients
Objectives
Transjugular intrahepatic portosystemic shunt (TIPS) is regularly used in treatment of clinically significant portal hypertension. Liver transplant r...
Outcomes in Cirrhotic Patients Receiving Transjugular Intrahepatic Portosystemic Shunt (TIPS) Versus Repeat Paracentesis for Recurrent Ascites
Outcomes in Cirrhotic Patients Receiving Transjugular Intrahepatic Portosystemic Shunt (TIPS) Versus Repeat Paracentesis for Recurrent Ascites
Abstract
Purpose: Many cirrhotic patients who cannot undergo liver transplantation are symptomatically treated for recurrent ascites with paracenteses and/or transjugular i...
Innovation in direct intrahepatic portosystemic shunt; a developing country experience
Innovation in direct intrahepatic portosystemic shunt; a developing country experience
Anticoagulants are the first-line treatment option for patients with Budd-Chiari syndrome (BCS); however, intervention is required when this fails. Although, the ultimate treatment...
Transjugular Intrahepatic Portosystemic Shunt for Budd–Chiari Syndrome: A Single-Centre Experience
Transjugular Intrahepatic Portosystemic Shunt for Budd–Chiari Syndrome: A Single-Centre Experience
Background: Despite several challenges in clinical management, there has been significant progress in understanding the aetiology, natural history and outcomes of Budd–Chiari syndr...
Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement
Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement
Abstract
Transjugular intra-hepatic portosystemic shunts (TIPS) had been considered a standard procedure in patients suffering from portal hypertension. The most challe...
A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease
A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease
Hepatic sinus obstruction syndrome (HSOS) is easy to be misdiagnosed or missed, and there is no unified and effective treatment for it. A patient was considered to have Budd-Chiari...
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature
Sinusoidal obstruction syndrome (SOS) is a rare, life-threatening clinical syndrome resulting from sinusoidal congestion, and it is characterized by hepatomegaly, ascites, weight g...
Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
ABSTRACT
Hepatic encephalopathy (HE) is a frequent complication that occurs following transjugular intrahepatic portosystemic shunt (TIPS) procedures and has a co...

